Carbamyl phosphate synthetase 1 deficiency: A destructive encephalopathy

被引:20
作者
Takeoka, M
Soman, TB
Shih, VE
Caviness, VS
Krishnamoorthy, KS
机构
[1] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA 02115 USA
关键词
D O I
10.1016/S0887-8994(00)00259-9
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Carbamyl phosphate synthetase I is a urea cycle enzyme. Severe deficiency of carbamyl phosphate synthetase I presents in the neonatal period as hyperammonemic encephalopathy with altered consciousness and occasional seizures after feeding begins. Episodes of altered consciousness with or without seizures and focal neurologic deficits are seen later with patients of partial carbamyl phosphate synthetase I deficiency. Fatal cerebral edema with brain herniation may develop on occasion. Three patients presenting with carbamyl phosphate synthetase I deficiency are reported with neuroimaging and pathologic findings illustrating the destructive encephalopathy with acute cerebral edema, followed by diffuse cerebral atrophy and occasional cystic encephalomalacia. The deterioration in carbamyl phosphate synthetase I deficiency occurs during the hyperammonemic crises. This deficiency may be difficult to treat despite the current advances in treatment strategies, especially in neonatal-onset patients with low carbamyl phosphate synthetase I activity. (C) 2001 by Elsevier Science Inc. All rights reserved.
引用
收藏
页码:193 / 199
页数:7
相关论文
共 24 条
[1]   CT and MRI in a girl with late-onset ornithine transcarbamylase deficiency: Case report [J].
Bajaj, SK ;
Kurlemann, G ;
Schuierer, GS ;
Peters, PE .
NEURORADIOLOGY, 1996, 38 (08) :796-799
[2]   The allopurinol load test lacks specificity for primary urea cycle defects but may indicate unrecognized mitochondrial disease [J].
Bonham, JR ;
Guthrie, P ;
Downing, M ;
Allen, JC ;
Tanner, MS ;
Sharrard, M ;
Rittey, C ;
Land, JM ;
Fensom, A ;
O'Neill, D ;
Duley, JA ;
Fairbanks, LD .
JOURNAL OF INHERITED METABOLIC DISEASE, 1999, 22 (02) :174-184
[3]   CARNITINE DEFICIENCY SYNDROMES [J].
BRENINGSTALL, GN .
PEDIATRIC NEUROLOGY, 1990, 6 (02) :75-81
[4]  
Brusilow S W, 1996, Adv Pediatr, V43, P127
[5]  
BRUSILOW SW, 1997, METABOLIC MOL BASIS, P1187
[6]   Effects of hyperammonaemia on brain function [J].
Butterworth, RF .
JOURNAL OF INHERITED METABOLIC DISEASE, 1998, 21 :6-20
[7]   CEREBRAL AMMONIA METABOLISM IN NORMAL AND HYPERAMMONEMIC RATS [J].
COOPER, AJL ;
LAI, JCK .
NEUROCHEMICAL PATHOLOGY, 1987, 6 (1-2) :67-95
[8]   Alternative pathway therapy for urea cycle disorders [J].
Feillet, F ;
Leonard, JV .
JOURNAL OF INHERITED METABOLIC DISEASE, 1998, 21 :101-111
[9]  
Frund S, 1996, CLIN NEPHROL, V46, P64
[10]   NEUROPATHOLOGY OF GALACTOSEMIA - HISTOPATHOLOGICAL AND BIOCHEMICAL STUDY [J].
HABERLAN.C ;
PEROU, M ;
BRUNNGRA.EG ;
HOF, H .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1971, 30 (03) :431-&